BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30808537)

  • 1. Characteristics and long-term survival of resected pancreatic cystic neoplasms in Finland. The first nationwide retrospective cohort analysis.
    Vaalavuo Y; Antila A; Ahola R; Siiki A; Vornanen M; Ukkonen M; Sand J; Laukkarinen J
    Pancreatology; 2019 Apr; 19(3):456-461. PubMed ID: 30808537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European evidence-based guidelines on pancreatic cystic neoplasms.
    European Study Group on Cystic Tumours of the Pancreas
    Gut; 2018 May; 67(5):789-804. PubMed ID: 29574408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of Incidentally Detected Pancreatic Cystic Neoplasms: Do Baseline MRI and CT Features Predict Cyst Growth?
    Pandey P; Pandey A; Luo Y; Aliyari Ghasabeh M; Khoshpouri P; Ameli S; O'Broin-Lennon AM; Canto M; Hruban RH; Goggins MS; Wolfgang C; Kamel IR
    Radiology; 2019 Sep; 292(3):647-654. PubMed ID: 31310174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of malignancy in small pancreatic cysts decreases over time.
    Ciprani D; Weniger M; Qadan M; Hank T; Horick NK; Harrison JM; Marchegiani G; Andrianello S; Pandharipande PV; Ferrone CR; Lillemoe KD; Warshaw AL; Bassi C; Salvia R; Fernández-Del Castillo C
    Pancreatology; 2020 Sep; 20(6):1213-1217. PubMed ID: 32819844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
    Cui M; Hu Y; Zhang Z; Chen T; Dai M; Xu Q; Guo J; Zhang T; Liao Q; Yu J; Zhao Y
    Signal Transduct Target Ther; 2023 Oct; 8(1):406. PubMed ID: 37848412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery?
    Puri PM; Watkins AA; Kent TS; Maggino L; Jeganathan JG; Callery MP; Drebin JA; Vollmer CM
    J Gastrointest Surg; 2018 Jan; 22(1):88-97. PubMed ID: 28875275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary mucinous neoplasms of the pancreas and European guidelines: importance of the surgery type in the decision-making process.
    Buscail E; Cauvin T; Fernandez B; Buscail C; Marty M; Lapuyade B; Subtil C; Adam JP; Vendrely V; Dabernat S; Laurent C; Chiche L
    BMC Surg; 2019 Aug; 19(1):115. PubMed ID: 31438917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society.
    Hirono S; Shimizu Y; Ohtsuka T; Kin T; Hara K; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Shimokawa T; Hijioka S; Yanagisawa A; Nakamura M; Okazaki K; Yamaue H
    J Gastroenterol; 2020 Jan; 55(1):86-99. PubMed ID: 31463655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
    Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
    Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European evidence-based guidelines on pancreatic cystic neoplasms (PCN) in clinical practice: The development of relative and absolute indications for surgery during prospective IPMN surveillance.
    Vaalavuo Y; Siiki A; Antila A; Rinta-Kiikka I; Sand J; Laukkarinen J
    Pancreatology; 2020 Oct; 20(7):1393-1398. PubMed ID: 32938553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent predictors of secondary invasive pancreatic remnant tumors after initial resection of an intraductal papillary mucinous neoplasm: a nationwide large-scale survey in Japan.
    Takigawa Y; Kitago M; Matsui J
    Surg Today; 2020 Dec; 50(12):1672-1680. PubMed ID: 32661567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of preoperative prognostic factors in patients with resectable invasive intraductal papillary mucinous carcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Surgery; 2020 Dec; 168(6):994-1002. PubMed ID: 32139141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological distress in patients under surveillance for intraductal papillary mucinous neoplasms of the pancreas: The "Sword of Damocles" effect calls for an integrated medical and psychological approach a prospective analysis.
    Marinelli V; Secchettin E; Andrianello S; Moretti C; Donvito S; Marchegiani G; Esposito A; Casetti L; Salvia R
    Pancreatology; 2020 Apr; 20(3):505-510. PubMed ID: 31948794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for pancreatic cancer in high-risk individuals.
    Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
    BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines.
    van Huijgevoort NCM; Del Chiaro M; Wolfgang CL; van Hooft JE; Besselink MG
    Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):676-689. PubMed ID: 31527862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a nomogram to predict the risk of cancer in patients with intraductal papillary mucinous neoplasm and main duct dilatation of 10 mm or less.
    Jung W; Park T; Kim Y; Park H; Han Y; He J; Wolfgang CL; Blair A; Rashid MF; Kluger MD; Su GH; Chabot JA; Yang CY; Lou W; Valente R; Del Chiaro M; Shyr YM; Wang SE; van Huijgevoort NCM; Besselink MG; Yang Y; Kim H; Kwon W; Kim SW; Jang JY
    Br J Surg; 2019 Dec; 106(13):1829-1836. PubMed ID: 31441048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcomes of intraductal papillary mucinous neoplasms.
    Hipp J; Mohamed S; Pott J; Sick O; Makowiec F; Hopt UT; Fichtner-Feigl S; Wittel UA
    BJS Open; 2019 Aug; 3(4):490-499. PubMed ID: 31388641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes.
    Luo G; Fan Z; Gong Y; Jin K; Yang C; Cheng H; Huang D; Ni Q; Liu C; Yu X
    Pancreas; 2019 Jul; 48(6):817-822. PubMed ID: 31210663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made?
    Lim J; Allen PJ
    Updates Surg; 2019 Jun; 71(2):209-216. PubMed ID: 31175628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions.
    Yoshioka T; Shigekawa M; Ikezawa K; Tamura T; Sato K; Urabe M; Sueyoshi H; Yamai T; Suda T; Sakamori R; Tatsumi T; Takehara T
    Pancreas; 2020 Apr; 49(4):552-560. PubMed ID: 32282769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.